Trans American Aquaculture (GRPS) Equity Average (2023 - 2025)
Trans American Aquaculture (GRPS) reported Equity Average of -$3.7 million for Q3 2025, down 177.63% on a YoY basis from $4.8 million in Q3 2024, and down 6.49% quarter-over-quarter from -$3.5 million in Q2 2025.
Trans American Aquaculture (GRPS) Equity Average (2023 - 2025) Analysis & Trends
Trans American Aquaculture has reported Equity Average for 3 years, with the latest figure at -$3.7 million in Q3 2025.
- For the quarter ending Q3 2025, Equity Average fell 177.63% year-over-year to -$3.7 million; the trailing twelve-month figure through Sep 2025 stood at -$3.7 million (down 177.63% YoY), and the FY2024 full-year result was -$1.9 million, down 3118.4% from the prior year.
- Equity Average for Q3 2025 stood at -$3.7 million, down from -$3.5 million in the prior quarter.
- The five-year high for Equity Average was $451045.5 in Q2 2023, with the low at -$3.7 million in Q3 2025.
- Historically, Equity Average has averaged -$1.3 million across 3 years, with a median of -$882453.5 in 2024.
- Annual changes were most pronounced in 2024 — Equity Average tumbled 1182.75% — and 2025, when it plunged 177.63%.
- Trans American Aquaculture's Equity Average stood at -$189742.0 in 2023, then plunged by 1182.75% to -$2.4 million in 2024, then tumbled by 53.62% to -$3.7 million in 2025.
- The last three Equity Average figures came in at -$3.7 million (Q3 2025), -$3.5 million (Q2 2025), and -$3.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | Trans American Aquaculture | - | - | - | -3.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.74 Mn |
| Jun 30, 2025 | -3.51 Mn |
| Mar 31, 2025 | -3.26 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -1.35 Mn |
| Jun 30, 2024 | -882,453.50 |
| Mar 31, 2024 | -598,287.50 |
| Dec 31, 2023 | -189,742.00 |
| Sep 30, 2023 | 272,902.00 |
| Jun 30, 2023 | 451,045.50 |
| Mar 31, 2023 | 410,177.00 |